BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 34685735)

  • 1. Quantifying Renin-Angiotensin-System Alterations in COVID-19.
    Pucci F; Annoni F; Dos Santos RAS; Taccone FS; Rooman M
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of renin-angiotensin-aldosterone system inhibitors on COVID-19.
    Matsuzawa Y; Kimura K; Ogawa H; Tamura K
    Hypertens Res; 2022 Jul; 45(7):1147-1153. PubMed ID: 35581498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: potential allies in the COVID-19 pandemic instead of a threat?
    Simko F; Baka T
    Clin Sci (Lond); 2021 Apr; 135(8):1009-1014. PubMed ID: 33881142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Covid-19: the renin-angiotensin system imbalance hypothesis.
    Lanza K; Perez LG; Costa LB; Cordeiro TM; Palmeira VA; Ribeiro VT; Simões E Silva AC
    Clin Sci (Lond); 2020 Jun; 134(11):1259-1264. PubMed ID: 32507883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypothesis for renin-angiotensin inhibitor mitigation of COVID-19.
    Sackin H
    Med Hypotheses; 2021 Jul; 152():110609. PubMed ID: 34048987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.
    Cheng H; Wang Y; Wang GQ
    J Med Virol; 2020 Jul; 92(7):726-730. PubMed ID: 32221983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The spike effect of acute respiratory syndrome coronavirus 2 and coronavirus disease 2019 vaccines on blood pressure.
    Angeli F; Zappa M; Reboldi G; Gentile G; Trapasso M; Spanevello A; Verdecchia P
    Eur J Intern Med; 2023 Mar; 109():12-21. PubMed ID: 36528504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between renin-angiotensin system and Severe Acute Respiratory Syndrome Coronavirus 2 infection: What do we know?
    Vitiello A; Ferrara F
    Eur J Pharmacol; 2020 Sep; 883():173373. PubMed ID: 32679185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling the Molecular Impact of SARS-CoV-2 Infection on the Renin-Angiotensin System.
    Pucci F; Bogaerts P; Rooman M
    Viruses; 2020 Nov; 12(12):. PubMed ID: 33265982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronavirus disease 2019 (COVID-19) and the renin-angiotensin system: A closer look at angiotensin-converting enzyme 2 (ACE2).
    Zemlin AE; Wiese OJ
    Ann Clin Biochem; 2020 Sep; 57(5):339-350. PubMed ID: 32369402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two hits to the renin-angiotensin system may play a key role in severe COVID-19.
    Tseng YH; Yang RC; Lu TS
    Kaohsiung J Med Sci; 2020 Jun; 36(6):389-392. PubMed ID: 32492292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repurposing of RAS-Pathway Mediated Drugs for Intestinal Inflammation Related Diseases for Treating SARS-CoV-2 Infection.
    Sinha A; Vaggu RG; Swain R; Patnaik S
    Curr Microbiol; 2023 Apr; 80(6):194. PubMed ID: 37106165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACE2: from protection of liver disease to propagation of COVID-19.
    Warner FJ; Rajapaksha H; Shackel N; Herath CB
    Clin Sci (Lond); 2020 Dec; 134(23):3137-3158. PubMed ID: 33284956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renin-Angiotensin System: An Important Player in the Pathogenesis of Acute Respiratory Distress Syndrome.
    Hrenak J; Simko F
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correcting the imbalanced protective RAS in COVID-19 with angiotensin AT2-receptor agonists.
    Steckelings UM; Sumners C
    Clin Sci (Lond); 2020 Nov; 134(22):2987-3006. PubMed ID: 33210709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights.
    Divani AA; Andalib S; Di Napoli M; Lattanzi S; Hussain MS; Biller J; McCullough LD; Azarpazhooh MR; Seletska A; Mayer SA; Torbey M
    J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104941. PubMed ID: 32689643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 Infections and ACE2: Clinical Outcomes Linked With Increased Morbidity and Mortality in Individuals With Diabetes.
    Obukhov AG; Stevens BR; Prasad R; Li Calzi S; Boulton ME; Raizada MK; Oudit GY; Grant MB
    Diabetes; 2020 Sep; 69(9):1875-1886. PubMed ID: 32669391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spike-mediated ACE2 down-regulation was involved in the pathogenesis of SARS-CoV-2 infection.
    Gao X; Zhang S; Gou J; Wen Y; Fan L; Zhou J; Zhou G; Xu G; Zhang Z
    J Infect; 2022 Oct; 85(4):418-427. PubMed ID: 35793758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of Membrane-bound Angiotensin Converting Enzyme 2 (ACE2) Receptor has a Pivotal Role in COVID-19 Immunopathology.
    Vieira C; Nery L; Martins L; Jabour L; Dias R; Simões E Silva AC
    Curr Drug Targets; 2021; 22(3):254-281. PubMed ID: 33081670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain Renin-Angiotensin System: From Physiology to Pathology in Neuronal Complications Induced by SARS-CoV-2.
    Ahmadi S; Khaledi S
    Anal Cell Pathol (Amst); 2023; 2023():8883492. PubMed ID: 37575318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.